48
Participants
Start Date
July 7, 2020
Primary Completion Date
December 30, 2022
Study Completion Date
November 30, 2023
UC-MSC infusion via intravenous route
Patients assigned to UC-MSC administration groups will receive two administrations at a dose of 1.5 million cells/kg patient body weight via the intravenous (IV) route with a 3-month intervening interval
UC-MSC infusion via intrathecal route
Patients assigned to UC-MSC administration groups will receive two administrations at a dose of 1.5 million cells/kg patient body weight via the intrathecal route with a 3-month intervening interval
standard stroke treatment and rehabilitation therapy
Each patient can receive up to 30 days of rehabilitation therapy
Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi
Vinmec Research Institute of Stem Cell and Gene Technology
OTHER